Expect a minority stake sale within 12 months to reset control dynamics around a €1.5b beauty franchise and €500m eyewear stream, with near-term margin stability for L'Oréal, option value creation for LVMH and EssilorLuxottica, and brand equity preserved if governance and license protections are secured.
Armani's will directs heirs to sell a 15% stake within 18 months with a path to majority after three years, triggering a strategic contest among L'Oréal Luxe, LVMH, and EssilorLuxottica. L'Oréal is reportedly focused solely on securing Armani beauty economics under its 2050 license, while LVMH and EssilorLuxottica face a choice between minority entry for governance rights or positioning for eventual control.
Next 30 to 90 days will see NDA execution, data room access, and non-binding indications of interest. L'Oréal will prioritize term-sheet protections around beauty rights rather than broad equity, including right of first refusal, post-2050 extension options, and change-of-control safeguards. LVMH must decide whether to lodge a minority bid despite beauty being contractually locked until 2050, aiming for board influence and future control. EssilorLuxottica can pursue a minority position tied to eyewear license extensions and product governance, potentially as the lowest-conflict strategic bidder.
Luxury demand is normalizing with China uneven and the Americas mixed, but prestige beauty remains resilient with mid to high single-digit growth and fragrance outperformance. The contest over Armani underscores a broader shift between asset-light licensing models and full ownership by conglomerates; L'Oréal defends licensed franchises at scale, LVMH pursues integrated brand ecosystems, and EssilorLuxottica drives category verticalization. Competitive pressure from Kering Beauty's build-out and Coty's licensing portfolio raises the strategic value of locking marquee licenses, while sustainability and Gen-Z preferences favor brands with strong fragrance storytelling and omnichannel execution.